Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe

Philipp Zanger(Unknown), Sabine Gabrysch(Heidelberg University), Ina Kötter(Eppendorf (Germany)), Peter G. Kremsner

Clinical Microbiology and Infection

September 15, 2011

10.1111/j.1469-0691.2011.03674.x

Cited by 65

Related Papers

Still too far to walk: Literature review of the determinants of delivery service use

|BMC Pregnancy and Childbirth|2009|1.3k

2018 update of the EULAR recommendations for the management of Behçet's syndrome

|Annals of the Rheumatic Diseases|2018|771

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

|JAMA|2014|739

EULAR recommendations for the management of Behçet disease

|Annals of the Rheumatic Diseases|2008|721

The Influence of Distance and Level of Care on Delivery Place in Rural Zambia: A Study of Linked National Data in a Geographic Information System

|PLoS Medicine|2011|359